Marketable Securities

9 Months Ended

Mar. 31, 2015

Marketable Securities

Marketable Securities

3.  Marketable Securities

The amortized cost and unrealized holding gains (losses) on our marketable securities were as follows as of March 31, 2015 and June 30, 2014:

	Fair Value		Cost		Unrealized Gains		Unrealized Losses
	(Dollars in Thousands)
March 31, 2015:
U.S. corporate bonds	$	71,848	$	71,863	$	13	$	(28	)
Total short-term marketable securities	$	71,848	$	71,863	$	13	$	(28	)
U.S. corporate bonds	$	9,140	$	9,152	$	2	$	(14	)
Total long-term marketable securities	$	9,140	$	9,152	$	2	$	(14	)
June 30, 2014:
U.S. corporate bonds	$	67,619	$	67,587	$	39	$	(7	)
Total short-term marketable securities	$	67,619	$	67,587	$	39	$	(7	)
U.S. corporate bonds	$	31,270	$	31,290	$	1	$	(21	)
Total long-term marketable securities	$	31,270	$	31,290	$	1	$	(21	)

Our marketable securities were classified as available-for-sale and reported at fair value on the unaudited consolidated balance sheets. Net unrealized gains (losses) were reported as a separate component of accumulated other comprehensive income, net of tax. Realized gains and (losses) on investments were recognized in earnings as incurred. Our investments consisted primarily of investment grade fixed income corporate debt securities with maturity dates ranging from April 2015 through August 2016 as of March 31, 2015 and from July 2014 through May 2016 as of June 30, 2014.

We review our marketable securities for impairment at each reporting period to determine if any of our securities have experienced an other-than-temporary decline in fair value in accordance with the provisions of ASC Topic 320, Investments- Debt and Equity Securities. We consider factors, such as the length of time and extent to which the market value has been less than the cost, the financial condition and near-term prospects of the issuer, our intent to sell, and whether it is more likely than not we will be required to sell the investment before recovery of its amortized cost basis. If we believe that an other-than-temporary decline in fair value has occurred, we write down the investment to fair value and recognize the credit loss in earnings and the non-credit loss in accumulated other comprehensive income. As of March 31, 2015 and 2014, our marketable securities were not considered other-than-temporarily impaired and, as such, we did not recognize impairment losses during the three and nine months periods then ended. Unrealized losses were attributable to changes in interest rates.